InsiderFlow

Thomas J. Schall

IMRX

Thomas J. Schall serves as director at Immuneering Corporation (IMRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

5 trades

$333.5K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$333.5K

Companies Traded

1

IMRX

Active Period

Mar 2024 – Jan 2026

5 total trades

Most Recent

Buy IMRX

Jan 20, 2026 · $101.0K

Thomas J. Schall's Insider Trading at Immuneering Corporation (IMRX)

Buys

5 · $333.5K

Sells

0 · $0.00

Total Shares Bought

96,175

Total Shares Sold

0

IMRX Price Chart
Loading chart...
DateTypeValue
Jan 20, 2026 Buy$101.0K
Jan 15, 2026 Buy$101.0K
Jun 27, 2025 Buy$34.8K
Jun 17, 2025 Buy$89.3K
Mar 25, 2024 Buy$7.4K